Amissa’s platform is informed by partnerships with leading research institutions and federal funders—but it is not itself a published clinical trial.
Helpful Details:
Amissa supports IRB-approved studies by granting secure access to de-identified patient data for research.
The platform is guided by expert clinicians and researchers from institutions like Brigham and Women’s Hospital, Mass General, Washington University School of Medicine, Wake Forest, and others.
Amissa has received funding from NIH and NSF to support research projects, machine learning efforts (including Alzheimer’s disease work), and wearable-based data collection initiatives.
Next Steps / Where to Go:
If you’re interested in understanding how Amissa’s data and analytics could support your research—or in exploring funding- or IRB-backed collaborations—reach out to our research team through the Help Center.